Interact to see
Advertisement
Advertisement
ADNRX vs PMAQX
ADNRX vs PMAQX Comparison
Open Charts ADNRX vs PMAQX
American Beacon ARK Transfmt Innov R6
Price$22.19
Change-$0.09 (-0.40%)
VolumeN/A
Net Assets220.9M
ADNRX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. PMAQX commentary
Sep 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and PMAQX is a Buy.
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33.2B vs. ADNRX (221M). PMAQX pays higher dividends than ADNRX: PMAQX (0.18) vs ADNRX (0.00). ADNRX was incepted earlier than PMAQX: ADNRX (5 years) vs PMAQX (9 years). ADNRX (1.13) is less costly to investors than PMAQX (0.59). ADNRX is a more actively managed with annual turnover of: 38.00 vs. PMAQX (10.50). ADNRX (0) and PMAQX (0) have matching initial minimum investment requirements. ADNRX annual gain was more profitable for investors over the last year : 75.14 vs. PMAQX (6.41).
| ADNRX | PMAQX | ADNRX / PMAQX | |
| Total Expense Ratio | 1.00 | 0.59 | 169% |
| Annual Report Gross Expense Ratio | 1.13 | 0.59 | 192% |
| Fund Existence | 5 years | 9 years | - |
| Gain YTD | 42.335 | 7.125 | 594% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 221M | 33.2B | 1% |
| Annual Yield % from dividends | 0.00 | 0.18 | - |
| Returns for 1 year | 75.14 | 6.41 | 1,172% |
| Returns for 3 years | 77.52 | 49.36 | 157% |
| Returns for 5 years | N/A | 51.01 | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers